Mechanisms of Opioid-Induced Tolerance and Hyperalgesia
Tóm tắt
Từ khóa
Tài liệu tham khảo
Angst, 2006, Opioid-induced hyperalgesia: a qualitative systematic review, Anesthesiology, 104, 570, 10.1097/00000542-200603000-00025
Arden, 1995, Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells, Journal of Neurochemistry, 65, 1636, 10.1046/j.1471-4159.1995.65041636.x
Benitez del Rosario, 2004, Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain, Cancer, 101, 2866, 10.1002/cncr.20712
Bergen, 1997, Mu opioid receptor gene variants: lack of association with alcohol dependence, Molecular Psychiatry, 2, 490, 10.1038/sj.mp.4000331
Bernstein, 1998, Proglumide as a morphine adjunct in cancer pain management, Journal of Pain & Symptom Management, 15, 314, 10.1016/S0885-3924(98)00003-7
Bohn, 2002, Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice, Journal of Neuroscience, 22, 10494, 10.1523/JNEUROSCI.22-23-10494.2002
Bohn, 1999, Enhanced morphine analgesia in mice lacking beta-arrestin 2, Science, 286, 2495, 10.1126/science.286.5449.2495
Bond, 1998, Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction, Proceeding of the National Academies of Science of the United States of America, 95, 9608, 10.1073/pnas.95.16.9608
Celerier, 2000, Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine, Anesthesiology, 92, 465, 10.1097/00000542-200002000-00029
Chavkin, 1982, Reduction in opiate receptor reserve in morphine tolerant guinea pig ilea, Life Sciences, 31, 1687, 10.1016/0024-3205(82)90186-2
Chavkin, 1984, Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus, Proceeding of the National Academies of Science of the United States of America, 81, 7253, 10.1073/pnas.81.22.7253
Chindalore, 2005, Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex, Journal of Pain, 6, 392, 10.1016/j.jpain.2005.01.356
Clark, 1995, Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient, Journal of Pain & Symptom Management, 10, 310, 10.1016/0885-3924(95)00010-V
Collin, 1993, Is disease progression the major factor in morphine “tolerance” in cancer pain treatment?, Pain, 55, 319, 10.1016/0304-3959(93)90007-C
Compton, 1994, Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status, Journal of Pain & Symptom Management, 9, 462, 10.1016/0885-3924(94)90203-8
Compton, 2001, Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent, Drug & Alcohol Dependence, 63, 139, 10.1016/S0376-8716(00)00200-3
Crain, 2000, Antagonists of excitatory opioid receptor functions enhance morphine’s analgesic potency and attenuate opioid tolerance/dependence liability, Pain, 84, 121, 10.1016/S0304-3959(99)00223-7
Davis, 1999, d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia, Journal of Pharmacol Exp Ther, 289, 1048
De Stoutz, 1995, Opioid rotation for toxicity reduction in terminal cancer patients, Journal of Pain Symptom & Management, 10, 378, 10.1016/0885-3924(95)90924-C
Dourish, 1988, Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718, European Journal of Pharmacology, 147, 469, 10.1016/0014-2999(88)90183-5
Doverty, 2001, Hyperalgesic responses in methadone maintenance patients, Pain, 90, 91, 10.1016/S0304-3959(00)00391-2
Drake, 2004, Opioid rotation in children with cancer, Journal of Palliative Medicine, 7, 419, 10.1089/1096621041349590
Duttaroy, 1995, The effect of intrinsic efficacy on opioid tolerance, Anesthesiology, 82, 1226, 10.1097/00000542-199505000-00018
Eilers, 2001, The reversal of fentanyl-induced tolerance by administration of “small-dose” ketamine, Anesthesia & Analgesia, 93, 213, 10.1097/00000539-200107000-00042
Elliott, 1994, Dextromethorphan attenuates and reverses analgesic tolerance to morphine, Pain, 59, 361, 10.1016/0304-3959(94)90022-1
Estfan, 2005, Opioid rotation in cancer patients: pros and cons, Oncology (Williston Park), 19, 511
Ferguson, 1998, Role of beta-arrestins in the intracellular trafficking of G-protein–coupled receptors, Advances in Pharmacology, 42, 420, 10.1016/S1054-3589(08)60778-4
Finn, 2001, Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal, Neuron, 32, 829, 10.1016/S0896-6273(01)00517-7
Foley, 1993, Changing concepts of tolerance to opioids: what the cancer patient has taught us, 331
Galer, 2005, MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance, Pain, 115, 284, 10.1016/j.pain.2005.03.004
Gardell, 2006, Opioid receptor–mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery, Neuroscience Letters, 396, 44, 10.1016/j.neulet.2005.11.009
Gardell, 2002, Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers, Journal of Neuroscience, 22, 6747, 10.1523/JNEUROSCI.22-15-06747.2002
Gorman, 1997, The d- and l-isomers of methadone bind to the noncompetitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord, Neuroscience Letters, 223, 5, 10.1016/S0304-3940(97)13391-2
Haley, 1990, Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat, Brain Research, 518, 218, 10.1016/0006-8993(90)90975-H
Hirota, 2003, Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy, Drug Metabolism & Disposition, 31, 677, 10.1124/dmd.31.5.677
Ho, 2006, Gabapentin and postoperative pain—a systematic review of randomized controlled trials, Pain, 126, 91, 10.1016/j.pain.2006.06.018
Indelicato, 2002, Opioid rotation in the management of refractory cancer pain, Journal of Clinical Oncology, 20, 348, 10.1200/JCO.2002.20.1.348
Ivarsson, 1989, Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance, Pharmacology & Toxicology, 65, 368, 10.1111/j.1600-0773.1989.tb01190.x
King, 2005, Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?, Neurosignals, 14, 194, 10.1159/000087658
Kloke, 2000, Toxicity and/or insufficient analgesia by opioid therapy: risk factors and the impact of changing the opioid, Support Care in Cancer, 8, 479, 10.1007/s005200000153
Lauretti, 1999, Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management, Anesthesiology, 90, 1528, 10.1097/00000542-199906000-00005
Li, 2000, Association analysis of polymorphisms in the DRD4 gene and heroin abuse in Chinese subjects, American Journal of Medical Genetics, 96, 616, 10.1002/1096-8628(20001009)96:5<616::AID-AJMG6>3.0.CO;2-7
Lotsch, 2002, The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine, Pharmacogenetics, 12, 3, 10.1097/00008571-200201000-00002
Lotsch, 2002, Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?, Anesthesiology, 97, 814, 10.1097/00000542-200210000-00011
Luttrell, 2002, The role of beta-arrestins in the termination and transduction of G-protein–coupled receptor signals, Journal of Cell Science, 115, 455, 10.1242/jcs.115.3.455
Lynch, 2005, A review of the use of methadone for the treatment of chronic noncancer pain, Pain Research & Management, 10, 133, 10.1155/2005/286713
Mansour, 1995, Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, Trends in Neuroscience, 18, 22, 10.1016/0166-2236(95)93946-U
Mansour, 1987, Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain, Journal of Neuroscience, 7, 2445
Mao, 2002, Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy, Pain, 100, 213, 10.1016/S0304-3959(02)00422-0
Mao, 2006, Opioid-induced abnormal pain sensitivity, Current Pain & Headache Reports, 10, 67, 10.1007/s11916-006-0011-5
Mao, 1994, Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C, Journal of Neuroscience, 14, 2301, 10.1523/JNEUROSCI.14-04-02301.1994
Mao, 1995, Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain, Pain, 61, 353, 10.1016/0304-3959(95)00022-K
Mao, 2002, Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity, Journal of Neuroscience, 22, 8312, 10.1523/JNEUROSCI.22-18-08312.2002
McCleane, 2004, Cholecystokinin antagonists a new way to improve the analgesia from old analgesics?, Current Pharmaceutical Design, 10, 303, 10.2174/1381612043386419
McCleane, 1998, The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain, Anesthesia & Analgesia, 87, 1117, 10.1213/00000539-199811000-00025
McCleane, 2003, The cholecystokinin antagonist proglumide enhances the analgesic effect of dihydrocodeine, Clinical Journal of Pain, 19, 200, 10.1097/00002508-200305000-00008
McNicol, 2003, Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review, Journal of Pain, 4, 231, 10.1016/S1526-5900(03)00556-X
Mercadante, 1996, Ketamine in cancer pain: an update, Palliative Medicine, 10, 225, 10.1177/026921639601000301
Mercadante, 1999, Opioid rotation for cancer pain: rationale and clinical aspects, Cancer, 86, 1856, 10.1002/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G
Morley, 1998, Opioid rotation: does it have a role?, Palliative Medicine, 12, 464, 10.1177/026921639801200611
Moulin, 1988, Unidirectional analgesic cross-tolerance between morphine and levorphanol in the rat, Pain, 33, 233, 10.1016/0304-3959(88)90095-4
Noble, 1996, Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment, British Journal of Pharmacology, 117, 161, 10.1111/j.1476-5381.1996.tb15169.x
Ossipov, 2005, Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure, Biopolymers, 80, 319, 10.1002/bip.20254
Pasternak, 2001, Incomplete cross tolerance and multiple mu opioid peptide receptors, Trends in Pharmacological Sciences, 22, 67, 10.1016/S0165-6147(00)01616-3
Perry, 2002, Arresting developments in heptahelical receptor signaling and regulation, Trends in Cell Biology, 12, 130, 10.1016/S0962-8924(01)02239-5
Price, 1985, Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist, Anesthesia & Analgesia, 64, 801, 10.1213/00000539-198508000-00010
Quigley, 2004, Opioid switching to improve pain relief and drug tolerability, Cochrane Database of Systematic Reviews, 3, CD004847
Quirion, 1984, Pain, nociception and spinal opioid receptors, Progress in Neuro-psychopharmacology & Biological Psychiatry, 8, 571, 10.1016/0278-5846(84)90017-4
Quirion, 1983, Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands, Life Sciences, 33, 227, 10.1016/0024-3205(83)90484-8
Raehal, 2005, Mu opioid receptor regulation and opiate responsiveness, AAPS Journal, 7, E587, 10.1208/aapsj070360
Ross, 2006, Clinical pharmacology and pharmacotherapy of opioid switching in cancer patients, Oncologist, 11, 765, 10.1634/theoncologist.11-7-765
Ross, 2005, Clinical response to morphine in cancer patients and genetic variation in candidate genes, Pharmacogenomics Journal, 5, 324, 10.1038/sj.tpj.6500327
Saeki, 1993, Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy, Anesthesia & Analgesia, 77, 265, 10.1213/00000539-199308000-00010
Sander, 1998, Human mu-opioid receptor variation and alcohol dependence, AlcoholismClinical & Experimental Research, 22, 2108
Shen, 1990, Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors, Brain Research, 525, 225, 10.1016/0006-8993(90)90868-C
Sim-Selley, 2000, Chronic heroin self-administration desensitizes mu opioid receptor–activated G-proteins in specific regions of rat brain, Journal of Neuroscience, 20, 4555, 10.1523/JNEUROSCI.20-12-04555.2000
Sim, 1996, Effects of chronic morphine administration on mu opioid receptor–stimulated [35S]GTPgammaS autoradiography in rat brain, Journal of Neuroscience, 16, 2684, 10.1523/JNEUROSCI.16-08-02684.1996
Sjogren, 1998, Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories, Acta Anaesthesiologica Scandinavica, 42, 1070, 10.1111/j.1399-6576.1998.tb05378.x
Sosnowski, 1990, Differential cross-tolerance between intrathecal morphine and sufentanil in the rat, Anesthesiology, 73, 1141, 10.1097/00000542-199012000-00012
Tang, 1984, Proglumide prevents and curtails acute tolerance to morphine in rats, Neuropharmacology, 23, 715, 10.1016/0028-3908(84)90171-0
Terman, 2004, G-Protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal, British Journal of Pharmacology, 141, 55, 10.1038/sj.bjp.0705595
Terner, 2006, Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains, Pain, 122, 90, 10.1016/j.pain.2006.01.019
Thomsen, 1999, Opioid rotation in chronic nonmalignant pain patients, Acta Anaesthesiologica Scandinavica, 43, 918, 10.1034/j.1399-6576.1999.430909.x
Town, 1999, Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency, American Journal of Medical Genetics, 88, 458, 10.1002/(SICI)1096-8628(19991015)88:5<458::AID-AJMG3>3.0.CO;2-S
Van Bockstaele, 1996, Ultrastructural evidence for prominent distribution of the mu-opioid receptor at extrasynaptic sites on noradrenergic dendrites in the rat nucleus locus coeruleus, Journal of Neuroscience, 16, 5037, 10.1523/JNEUROSCI.16-16-05037.1996
Vanderah, 2000, Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance, Journal of Neuroscience, 20, 7074, 10.1523/JNEUROSCI.20-18-07074.2000
Vanderah, 2001, Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance, Journal of Neuroscience, 21, 279, 10.1523/JNEUROSCI.21-01-00279.2001
Vigano, 1996, Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators, Pain, 67, 115, 10.1016/0304-3959(96)03112-0
Wang, 2005, Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor–G protein coupling and Gbetagamma signaling, Neuroscience, 135, 247, 10.1016/j.neuroscience.2005.06.003
Watkins, 1984, Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide, Science, 224, 395, 10.1126/science.6546809
White, 2005, The changing role of nonopioid analgesic techniques in the management of postoperative pain, Anesthesia & Analgesia, 101, S5, 10.1213/01.ANE.0000177099.28914.A7
Xu, 1992, CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat, British Journal of Pharmacology, 105, 591, 10.1111/j.1476-5381.1992.tb09024.x
Yabaluri, 1997, Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling, Molecular Pharmacology, 52, 896, 10.1124/mol.52.5.896